BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 17035927)

  • 21. World wide experience with inactivated poliovirus vaccine.
    Bonnet MC; Dutta A
    Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
    Friedrich F
    Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strengths and weaknesses of current polio vaccines--a view from industry.
    André FE
    Dev Biol (Basel); 2001; 105():61-6. PubMed ID: 11763338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.
    Hampton LM; Farrell M; Ramirez-Gonzalez A; Menning L; Shendale S; Lewis I; Rubin J; Garon J; Harris J; Hyde T; Wassilak S; Patel M; Nandy R; Chang-Blanc D;
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(35):934-8. PubMed ID: 27606675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z
    Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress toward interruption of wild poliovirus transmission--worldwide, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(12):308-12. PubMed ID: 19343011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory surveillance for wild and vaccine-derived polioviruses, January 2004-June 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(38):958-61. PubMed ID: 16195695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccine-derived polioviruses.
    Burns CC; Diop OM; Sutter RW; Kew OM
    J Infect Dis; 2014 Nov; 210 Suppl 1():S283-93. PubMed ID: 25316847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory surveillance for wild and vaccine-derived polioviruses, January 2003-June 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Oct; 53(42):990-3. PubMed ID: 15514582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress toward interruption of wild poliovirus transmission--worldwide, January 2006-May 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jul; 56(27):682-5. PubMed ID: 17625496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses - Worldwide, July 2018-December 2019.
    Macklin G; Diop OM; Humayun A; Shahmahmoodi S; El-Sayed ZA; Triki H; Rey G; Avagyan T; Grabovac V; Jorba J; Farag N; Mach O
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(28):913-917. PubMed ID: 32673297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polio eradication: the OPV paradox.
    Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ
    Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress toward poliomyelitis eradication--Nigeria, 2005-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):278-81. PubMed ID: 17392680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory surveillance for wild and vaccine-derived polioviruses--worldwide, January 2006-June 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(37):965-9. PubMed ID: 17882127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress toward global poliomyelitis eradication--1997-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 May; 48(20):416-21. PubMed ID: 10365631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory surveillance for wild poliovirus and vaccine-derived poliovirus, 2000-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 May; 51(17):369-71. PubMed ID: 12018383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Notes from the Field: Circulating Vaccine-Derived Poliovirus Outbreaks - Five Countries, 2014-2015.
    Morales M; Nnadi CD; Tangermann RH; Wassilak SG
    MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(5):128-9. PubMed ID: 26866942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.